4-(4-(Allyloxy)benzoyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-1H-pyrrol-2(5H)-one

Catalog No. :
ACBQGK557
CAS No. :
618077-22-8
Molecular Formula :
C25H27NO7
Molecular Weight :
453.49

IUPAC Name:4-(4-(allyloxy)benzoyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-1,5-dihydro-2H-pyrrol-2-one

4-(4-(Allyloxy)benzoyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-1H-pyrrol-2(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-(Allyloxy)benzoyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-1H-pyrrol-2(5H)-one
IUPAC Name4-(4-(allyloxy)benzoyl)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-1,5-dihydro-2H-pyrrol-2-one
MDL No.MFCD04195893
Molecular FormulaC25H27NO7
Molecular Weight453.49
SMILESC=CCOC1=CC=C(C(=O)C2=C(O)C(=O)N(CCCOC)C2C2=CC=C(O)C(OC)=C2)C=C1
InChI KeyQTMNVQYKENLJFC-UHFFFAOYSA-N
Synonym3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-4-{[4-(prop-2-en-1-yloxy)phenyl]carbonyl}-1,5-dihydro-2H-pyrrol-2-one;SALOR-INT L430781-1EA;4-[4-(ALLYLOXY)BENZOYL]-3-HYDROXY-5-(4-HYDROXY-3-METHOXYPHENYL)-1-(3-METHOXYPROPYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE;2H-Pyrrol-2-one, 1,5-dihydro-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-1-(3-methoxypropyl)-4-[4-(2-propen-1-yloxy)benzoyl]-
CAS No.618077-22-8

Synthetic Route by SureRoute

1. ACBQGK557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQGK557 route product structure diagram
    ACBQGK557618077-22-8
Inquiry

2. ACBQGK557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBQGK557 route product structure diagram
    ACBQGK557618077-22-8
Inquiry

Comments (0)